BIOR News and Press, Biora Therapeutics Inc. From 01/19/23

SAN DIEGO, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today presented detailed results from its PM-611 study titled “Potential effects of food on a novel Drug Delivery System (DDS) to deliver...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Michael Vi / Shutterstock It’s the return of the meme stocks on Wednesday as Bed Bath & Beyond (NASDAQ: BBBY ), AMC Entertainment (NYSE: AMC ), and GameStop (NYSE: GME ) are all on the...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: frank_peters / Shutterstock.com Travelers around the U.S. are wondering why there are so many flight delays today and we have the answer. Those stuck in airport terminals can look to the Federal Aviation Admini...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Spyro the Dragon/Shutterstock.com Fans of Jaguar Health (NASDAQ: JAGX ) stock will want to keep an eye on the company tomorrow as it prepares for an investor webcast . Investors will want to tune into tha...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Biora Therapeutics (NASDAQ: BIOR ) stock is on the rise Wednesday following news of feedback from the FDA. Today’s news concerns the company’s Targeted Therapeutics Platform and ...

After a more than twofold rise in the previous session, nano-cap biotech Biora Therapeutics ( NASDAQ: BIOR ) added ~29% in the pre-market trading Wednesday in a rally driven by the FDA feedback on its PGN-600 program targeted at ulcerative colitis. PGN-600 is designed to deliver a...

If you’re looking for penny stocks to buy, short-squeeze stocks have gained some appeal in the stock market today. One of the primary reasons for this is the potential that some of these types of stock hold for incredible breakouts – and breakdowns, for that matter. While short sque...

SAN DIEGO, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced feedback from the United States Food and Drug Administration (FDA) on its clinical development plans for its PGN-600 program, an...

Biora Therapeutics ( NASDAQ: BIOR ), a biotech focused on oral biotherapeutics, announced Friday that its common stock would start trading on a split-adjusted basis when the market opens on Jan. 03 following a 1-for-25 reverse stock split. After the reverse stock split, the number of ...

SAN DIEGO, Dec. 30, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced it will effect a reverse stock split of all outstanding shares of the company’s common stock at a ratio of 25 to 1. The c...